JP2024504914A5 - - Google Patents

Info

Publication number
JP2024504914A5
JP2024504914A5 JP2023540739A JP2023540739A JP2024504914A5 JP 2024504914 A5 JP2024504914 A5 JP 2024504914A5 JP 2023540739 A JP2023540739 A JP 2023540739A JP 2023540739 A JP2023540739 A JP 2023540739A JP 2024504914 A5 JP2024504914 A5 JP 2024504914A5
Authority
JP
Japan
Prior art keywords
medium
vector
serum
cell line
viral vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023540739A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024504914A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/141958 external-priority patent/WO2022143623A1/zh
Publication of JP2024504914A publication Critical patent/JP2024504914A/ja
Publication of JP2024504914A5 publication Critical patent/JP2024504914A5/ja
Pending legal-status Critical Current

Links

JP2023540739A 2020-12-29 2021-12-28 高分散性hek293t細胞株及びそのスクリーニング方法 Pending JP2024504914A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202011592436 2020-12-29
CN202011592436.6 2020-12-29
PCT/CN2021/141958 WO2022143623A1 (zh) 2020-12-29 2021-12-28 高分散性的hek293t细胞株及其筛选方法

Publications (2)

Publication Number Publication Date
JP2024504914A JP2024504914A (ja) 2024-02-02
JP2024504914A5 true JP2024504914A5 (cg-RX-API-DMAC7.html) 2026-03-04

Family

ID=82260222

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023540739A Pending JP2024504914A (ja) 2020-12-29 2021-12-28 高分散性hek293t細胞株及びそのスクリーニング方法

Country Status (6)

Country Link
US (1) US20240101964A1 (cg-RX-API-DMAC7.html)
EP (1) EP4273236A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024504914A (cg-RX-API-DMAC7.html)
KR (1) KR20230126214A (cg-RX-API-DMAC7.html)
CN (1) CN116635088A (cg-RX-API-DMAC7.html)
WO (1) WO2022143623A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240425880A1 (en) * 2021-10-12 2024-12-26 Jiangsu Genscript Probio Biotech Co., Ltd. Hek293 cell line adapted to serum-free suspension culture and use thereof
PL445894A1 (pl) * 2023-08-24 2025-03-03 Famicordtx Spółka Akcyjna Zestaw kompozycji podłoży do oczyszczania, zatężania i diafiltracji wektorów wirusowych, zastosowanie zestawu oraz sposób zatężania, oczyszczania i diafiltracji wektorów wirusowych
CN117247972B (zh) * 2023-11-20 2024-02-13 恺佧生物科技(上海)有限公司 一种快速高成功率筛选Expi293稳转细胞株的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI239352B (en) * 1997-07-23 2005-09-11 Takara Bio Inc Gene transfer method with the use of serum-free medium
WO2013076309A1 (en) * 2011-11-24 2013-05-30 Genethon Scalable lentiviral vector production system compatible with industrial pharmaceutical applications
CN102604889B (zh) * 2012-03-19 2013-05-08 中国农业科学院哈尔滨兽医研究所 适应无血清培养的hek293细胞系及其应用
PT2970920T (pt) * 2013-03-15 2018-07-30 Childrens Hospital Philadelphia Processo de fabrico escalável para produzir vetores lentivirais recombinantes em sistema de cultura de células de suspensão livres de soro
CN104450607B (zh) * 2014-11-14 2017-07-11 武汉金开瑞生物工程有限公司 用于hek293细胞悬浮生长的全化学成分培养基及培养方法
US11208630B2 (en) * 2015-12-24 2021-12-28 University Of Florida Research Foundation, Incorporated AAV production using suspension adapted cells
JP7374119B2 (ja) * 2018-04-05 2023-11-06 ジェネトン 減少した肝臓向性を有するAAV9とAAVrh74とのハイブリッド組換えアデノ随伴ウイルス血清型

Similar Documents

Publication Publication Date Title
JP2024538792A5 (cg-RX-API-DMAC7.html)
CN110713971B (zh) 一种无血清悬浮培养型293t细胞、其制备方法以及病毒的包装方法
AU2015297347B2 (en) Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method
Yang et al. Generation of iPSCs as a pooled culture using magnetic activated cell sorting of newly reprogrammed cells
AR033993A1 (es) Metodo para producir reovirus infeccioso y de mamifero, y composicion de reovirus
CN111826341A (zh) 一种体外培养hek293细胞用于瞬时表达蛋白的方法
CN104812893A (zh) 高感染滴度的细小病毒的生产方法
WO2014196795A1 (ko) 무단백 배지에서 부유 배양되는 mdck 유래 세포주 및 상기 세포주를 이용하여 바이러스를 증식시키는 방법
JP7717458B2 (ja) 無血清培地によりキメラ抗原レセプターt細胞を調製する方法
CN110951681A (zh) 一种间充质干细胞培养基
Soboleva et al. Establishment of an immortalized human erythroid cell line sustaining differentiation potential without inducible gene expression system
Gao et al. A scalable culture system incorporating microcarrier for specialised mesenchymal stem cells from human embryonic stem cells
CN107034238A (zh) 一种永生化特络细胞系及其构建方法
WO2023072178A1 (en) Methods for developing a cell line for producing virus in suspension cell culture
CN104745529B (zh) 瘦素在诱导胚胎干细胞分化为造血干/祖细胞中的用途及其应用
CN102911911B (zh) 人胚肾细胞293t-c10单克隆细胞株及其制备和应用
CN105316286A (zh) 一种制备重组间充质干细胞的方法及其得到的重组间充质干细胞
CN106916780B (zh) 高密度悬浮培养的bhk21细胞克隆株
CN114774351A (zh) 牙鲆卵原干细胞培养液及牙鲆卵原干细胞体外培养方法及应用
CN119876273A (zh) 一种嵌合抗原受体nk细胞的制备方法及其应用
CN119351341A (zh) 基因工程化的成纤维细胞及其制备方法、增殖和/或分化b细胞的培养基与应用
CN117866895A (zh) 一种pbmc细胞永生化的培养方法
CN116515728A (zh) 无弹状病毒的Sf9-PT细胞及其应用
JP7141043B2 (ja) 人工多能性幹細胞の評価方法及び選抜方法、並びに人工多能性幹細胞の製造方法
CN113322234A (zh) 永生化人cd34+cd38-造血干细胞系的制备方法及应用